Core Viewpoint - Nanjing Central Mall (Group) Co., Ltd. has been named by regulators for failing to disclose significant litigation developments in a timely manner, leading to inaccurate financial reporting for the first half of 2025 [1][2]. Group 1: Regulatory Actions - The Jiangsu Securities Regulatory Bureau issued an administrative regulatory measure against the company and relevant responsible persons, resulting in a warning letter being placed in the securities and futures market integrity file [1]. - The Shanghai Stock Exchange also announced a regulatory warning against the company and the responsible individuals on the same evening [1]. Group 2: Litigation Details - The company disclosed on July 13, 2024, that its subsidiary, Xuzhou Central Department Store Co., Ltd., was involved in a lawsuit with Xuzhou Xulai Cultural Communication Co., Ltd. over a rental contract dispute, with the amount in question being approximately 8.7977 million yuan [1]. - On October 30, 2025, the company provided a supplemental disclosure regarding the litigation progress, stating that a first-instance judgment was received on July 2, 2025, and an appeal was filed on July 16, 2025, with mediation reached on October 24, 2025 [2]. Group 3: Compliance and Impact - Industry experts emphasized the importance of timely disclosure of significant litigation developments to protect investors' rights, noting that the company delayed its disclosure by nearly four months, which is a serious violation of the "timeliness" principle [2]. - Legal professionals indicated that negative records in the integrity file could impact the management's future qualifications for positions in listed and non-listed public companies, as regulatory bodies scrutinize such records during appointment reviews [2].

Group 1 - The company held its third extraordinary general meeting of shareholders on November 21, 2025, at its headquarters in Nanjing, with all resolutions passed without any objections [2][4] - The meeting was chaired by the company's chairman, Zhu Jun, and followed the voting procedures as per the Company Law and Articles of Association [2][4] - The meeting included the attendance of all seven current directors and the board secretary, Li You [3] Group 2 - The company received a warning letter from the Jiangsu Securities Regulatory Bureau due to failure to timely disclose significant litigation developments related to a rental contract dispute involving its subsidiary [7][8] - The warning letter indicated that the company, along with its chairman, board secretary, and financial director, failed to comply with the information disclosure regulations, leading to inaccuracies in the 2025 semi-annual report [8][10] - The company acknowledged the issues raised in the warning letter and committed to improving compliance with legal and regulatory requirements to prevent future occurrences [10]

Group 1 - Central Plaza received a warning letter from Jiangsu Securities Regulatory Commission due to failure to timely disclose significant litigation progress and accounting treatment, affecting the accuracy of the 2025 semi-annual report [4] - Jiaron Technology announced a stock suspension as it plans a major asset restructuring through share issuance and fundraising, with the suspension expected to last no more than 10 trading days [5] - Maiwei Co. is undergoing a debt restructuring involving accounts receivable totaling 371 million yuan, with an estimated loss of 85.465 million yuan, aimed at accelerating cash flow recovery and reducing receivables risk [6] Group 2 - New World plans to use up to 850 million yuan of idle fundraising to purchase financial products or deposits, having previously used 575 million yuan for similar purposes [7] - Huyou Pharmaceutical's HYP-6589 tablet clinical trial application for treating advanced non-small cell lung cancer has been accepted by the National Medical Products Administration [8] - Sunshine Nuohuo's lawsuit against Hengsheng Pharmaceutical has entered the second instance, with the original claim amounting to 20 million yuan and a counterclaim of 740.73 thousand yuan [9] Group 3 - Guolian Aquatic received a warning letter from Guangdong Securities Regulatory Commission for non-operating fund occupation by its controlling shareholder, with a total borrowing of 7.8 million yuan [10] - Renfu Pharmaceutical's application for the marketing authorization of Dexmethylphenidate capsules has been accepted, targeting ADHD treatment [11] - Jindi Co. signed a strategic cooperation letter with Dongpei Co. to explore collaboration on humanoid robot harmonic reducer assemblies [12] Group 4 - Yuyuan Co. repurchased 1 million A-shares for a total payment of approximately 5.386 million yuan, as part of a broader repurchase plan of 200-300 million yuan [13] - Yuheng Pharmaceutical's executives increased their holdings by 1.12% through a judicial auction, acquiring 25 million shares [14] - Zhonghuan Co. shareholders plan to reduce their holdings by 1.02% and 0.24% respectively, citing personal funding needs [15] Group 5 - Huibo Co. won a contract for the Iraq NaftKhana oilfield restoration project worth approximately 1.596 billion yuan, expected to significantly impact 2026-2027 performance [17] - Dajin Heavy Industry's subsidiary signed a contract for a European offshore wind farm project valued at approximately 1.339 billion yuan, representing 35.41% of the company's 2024 audited revenue [18]

Regulatory Actions - Haosai is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure, but the company states that its operations remain normal and the investigation will not significantly impact management [2] - Central Plaza and its executives received a warning letter from the Jiangsu Securities Regulatory Bureau for failing to timely disclose significant litigation progress, which led to inaccurate financial reporting [3] - Guolian Aquatic received a warning letter from the Guangdong Securities Regulatory Bureau for non-operating fund occupation by its controlling shareholder, which was not disclosed in a timely manner [9] Corporate Actions - Jiarong Technology is planning a major asset restructuring and has suspended trading of its shares, expected to last no more than 10 trading days [4] - Maiwei Co. announced a debt restructuring totaling 371 million yuan, with an expected loss of 85.465 million yuan, aimed at improving cash flow and reducing receivables risk [5] - New World plans to use up to 850 million yuan of idle fundraising to purchase financial products or deposits, with a total of 575 million yuan already invested in such products [6] Legal Matters - Sunshine Nuohuo's lawsuit against Hengsheng Pharmaceutical has entered the second instance, with the original claim amounting to 20 million yuan and a counterclaim of 7.4073 million yuan [8] Product Development - Huyou Pharmaceutical's HYP-6589 tablet has received acceptance for clinical trial applications for treating advanced non-small cell lung cancer [7] - Renfu Pharmaceutical's application for the marketing license of a new ADHD treatment has been accepted, with no similar products currently available in the domestic market [10] Strategic Partnerships - Jindi Co. signed a strategic cooperation letter of intent with Dongpei Co. to explore collaboration on humanoid robot harmonic reducer assemblies and key components [11] Share Buybacks and Holdings - Yuyuan Co. has repurchased 1 million A-shares for a total of approximately 5.3864 million yuan as part of a buyback plan [12] - Yuheng Pharmaceutical's executives increased their holdings by 1.12%, acquiring a total of 25 million shares [13] Major Contracts - Huayou Huibo has been awarded a contract worth 225 million USD for the Iraq NaftKhana oilfield project, which is expected to significantly impact future earnings [16] - Dajin Heavy Industry's subsidiary signed a contract worth approximately 1.339 billion yuan for a European offshore wind farm project, representing 35.41% of the company's expected annual revenue [17]

证券代码：600280 证券简称：中央商场 公告编号：临 2025-049 如果对本监督管理措施不服，可以在收到本决定书之日起 60 日内向中国证 券监督管理委员会提出行政复议申请，也可以在收到本决定书之日起 6 个月内向 有管辖权的人民法院提起诉讼。复议与诉讼期间，上述监督管理措施不停止执行。 二、其他说明 南京中央商场（集团）股份有限公司（以下简称"公司"）于近日收到中国证 券监督管理委员会江苏监管局（以下简称"江苏证监局"）下发的行政监管措施决 定书《江苏证监局关于对南京中央商场（集团）股份有限公司及相关责任人采取 出具警示函措施的决定》（〔2025〕202 号）（以下简称"《警示函》"）。根 据相关要求，现将《警示函》主要内容公告如下： 一、《警示函》主要内容 南京中央商场（集团）股份有限公司、祝珺、李尤、金福： 你公司在子公司徐州中央百货大楼股份有限公司与徐州旭来文化传播有限 公司房屋租赁合同纠纷一案中，未及时披露重大诉讼进展情况，亦未按照企业会 计准则规定及时进行会计处理，导致 2025 年半年报信息披露不准确。 公司的上述行为违反了《上市公司信息披露管理办法》（证监会令第 182 号）（以下简称 ...

南京市汉中门大街 309号 B 座 5 B. 309 Hanzhongmen Daije, Naniing, Chin 国浩律师(南京)事务所 关于 南京中央商场(集团)股份有限公司 2025年第三次临时股东会的法律意见书 经本所律师核查,本次会议由公司第十届董事会第八次会议决定召集。2025 年10月28日,公司第十届董事会第八次会议通过决议,提议召开本次会议。2025 年10月30日,公司发出了召开本次会议的通知。前述董事会决议及股东会会议通 知已在上海证券交易所网站(www. sse. com. cn)上进行了公告。公告载明了本次会 议的会议时间、现场会议召开地点、会议表决方式、会议审议事项、股东会投票 注意事项、会议出席对象、会议登记方法等事项。会议通知内容符合《公司法》 《股东会规则》《监管指引第1号》等法律、法规和《公司章程》的规定。 本次会议采取现场投票和网络投票相结合的方式召开。现场会议于2025年11 月21日(星期五)下午14时00分在南京市建邺区雨润路10号公司二楼会议室召开, 现场会议召开的时间、地点、审议的事项与公告通知的内容一致。本次会议的网 络投票通过上海证券交易所网络投票系统进 ...

证券代码：600280 证券简称：中央商场 公告编号：2025-050 南京中央商场（集团）股份有限公司 2025年第三次临时股东会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 本次股东会由公司董事会召集，公司董事长祝珺先生主持，采取记名投票表 决的方式审议通过会议议案，符合《公司法》和《公司章程》的规定。公司董事、 高级管理人员、律师事务所律师出席了本次会议。 (五)公司董事和董事会秘书的列席情况 1、公司在任董事7人，列席7人； 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 (一)股东会召开的时间：2025 年 11 月 21 日 (二)股东会召开的地点：南京市建邺区雨润路 10 号公司二楼会议室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 359 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 172,998,787 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | ...

证券之星消息，11月21日一般零售板块较上一交易日下跌2.89%，中央商场领跌。当日上证指数报收于 3834.89，下跌2.45%。深证成指报收于12538.07，下跌3.41%。一般零售板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 605188 | 国光连锁 | 23.65 | 3.64% | 31.03万 | | 7.40亿 | | 300947 | 德必集团 | 19.66 | 2.88% | 12.21万 | | 2.42亿 | | 600415 | 小商品城 | 15.72 | -0.44% | 38.21万 | | 6.04亿 | | 600729 | 重庆百货 | 26.85 | -0.85% | - 3.31万 | 8931.86万 | | | 600605 | 汇通能源 | 27.54 | -1.15% | 2.24万 | 6243.58万 | | | 600693 | 东百集团 | 8.57 | -1.27% | 132.51万 | | ...

中央商场晚间公告，公司及相关人员收到江苏证监局警示函，因未及时披露子公司徐州中央百货大楼股 份有限公司与徐州旭来文化传播有限公司房屋租赁合同纠纷进展，以及未按规定进行会计处理，导致 2025年半年报信息披露不准确。公司将加强法律法规学习，提高信息披露质量。 （文章来源：第一财经） ...

Core Points - The company and its executives received a warning letter from the Jiangsu Securities Regulatory Bureau due to failure to timely disclose significant litigation progress related to a subsidiary's lease contract dispute [1] - The inaccurate information disclosure in the 2025 semi-annual report was attributed to the company's delayed accounting treatment [1] - The regulatory body has mandated the company to submit a written report within 10 working days and has recorded the warning in the company's integrity file [1] - The company has stated that it will enhance learning and implement strict rectifications, emphasizing that the regulatory measures will not affect normal operations [1]